NCT03355365: A trial that was reported late by Tisch Multiple Sclerosis Research Center of New York
This trial has reported, although it was 376 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03355365 |
|---|---|
| Title | Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 21, 2018 |
| Completion date | Feb. 9, 2023 |
| Required reporting date | Feb. 9, 2024, midnight |
| Actual reporting date | Feb. 19, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 376 |